fexofenadine has been researched along with diphenylcyclopropenone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, S; Fujiwara, S; Hatano, Y; Katagiri, K | 1 |
| Inui, S; Itami, S; Nakajima, T; Toda, N | 1 |
2 other study(ies) available for fexofenadine and diphenylcyclopropenone
| Article | Year |
|---|---|
Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Cohort Studies; Cyclopropanes; Dermatitis, Contact; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Pruritus; Risk Assessment; Severity of Illness Index; Terfenadine; Treatment Outcome | 2006 |
Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Cyclobutanes; Cyclopropanes; Dermatologic Agents; Female; Humans; Hypersensitivity; Immunotherapy; Male; Middle Aged; Retrospective Studies; Terfenadine; Young Adult | 2009 |